A naukri.com initiative
Bioengineer
1w
87
Image Credit: Bioengineer
Mass General Brigham Researchers Unveil Key Findings at ASCO Conference
- Researchers from Mass General Brigham will present groundbreaking advancements in cancer therapy and supportive care at the 2025 ASCO Annual Meeting, showcasing investigations from clinical trials conducted across their institutions.
- One focus is the INCIPIENT trial, exploring CAR T-cell therapy targeting recurrent glioblastoma using a dual-action approach to broaden the immune attack on tumor heterogeneity.
- Initial findings show sustained presence of CAR T cells in the cerebrospinal fluid post-intraventricular delivery, shedding light on local immune dynamics.
- Results from safety assessments of CARv3-TEAM-E demonstrate successful manufacturing of CAR T cells and tolerable safety profiles, paving the way for expanding CAR T therapeutics for glioblastoma.
- A psychosocial digital application, the BMT-CARE App, aims to transform supportive care for caregivers of hematopoietic stem cell transplant patients, showing significant improvements in caregiver quality of life and coping strategies.
- Research led by Dr. Ayal A. Aizer compares stereotactic radiation with hippocampal avoidance whole brain radiation in patients with multiple brain metastases, demonstrating improved outcomes with SRS/SRT.
- Studies on vulvar cancer and melanoma explore combinations of therapies to enhance treatment efficacy, while advancements in neoadjuvant checkpoint therapy in melanoma aim to improve pathological response rates.
- The presentations at ASCO 2025 highlight Mass General Brigham's commitment to cancer research through innovative immunotherapies, precision radiation techniques, and digital tools for caregiver support.
- These studies demonstrate next-generation strategies addressing cancer management challenges, such as tumor heterogeneity, caregiver support, and optimization of radiation therapy for improved outcomes and quality of life.
- The findings presented at the ASCO conference will contribute to shaping the future of oncology research and patient care by translating clinical discoveries into practice and fostering collaborative advancements in the field.
- Mass General Brigham's pivotal role in advancing cancer care through innovative treatments and patient-centered interventions is underscored by the diverse array of research presented at ASCO 2025.
Read Full Article
5 Likes
For uninterrupted reading, download the app